Valuation: PharmaEssentia Corporation

Market Cap 493B 15.32B 13.77B 12.85B 11.65B 21.87B 1,458B 22B 154B 60.22B 757B 57.51B 56.26B 2,433B P/E 2026 *
43.1x
P/E 2027 * 27.1x
Enterprise Value 467B 14.51B 13.04B 12.17B 11.03B 20.71B 1,380B 20.84B 146B 57.03B 716B 54.46B 53.28B 2,304B EV / Sales 2026 *
16.3x
EV / Sales 2027 * 11.1x
Free-Float
79.23%
Yield 2026 *
0.34%
Yield 2027 * 0.2%
1 day+2.15%
1 week+1.28%
Current month-2.06%
1 month-7.03%
3 months-4.80%
6 months+104.02%
Current year+180.86%
1 week 1,155
Extreme 1155
1,235
1 month 1,125
Extreme 1125
1,240
Current year 423.7
Extreme 423.699083
1,645
1 year 407.92
Extreme 407.923053
1,645
3 years 228.27
Extreme 228.269713
1,645
5 years 68.72
Extreme 68.724617
1,645
10 years 43.54
Extreme 43.541837
1,645
Manager TitleAgeSince
Chief Executive Officer - 01/01/2017
Director of Finance/CFO - 14/10/2015
President - 25/06/2015
Director TitleAgeSince
Director/Board Member - 09/05/2000
Chairman - 24/09/2012
Director/Board Member - 29/05/2015
Change 5-day change 1-year change 3-year change Capi.($)
+2.15%+1.28%+152.40%+365.04% 15B
-2.01%-7.86%+54.60%+70.97% 70.44B
+3.84%-11.02%+8.59%+58.77% 50.31B
+3.35%+1.42%+11.85%+37.39% 47.51B
+0.90%+1.62%+28.10%+31.82% 42.91B
+3.01%-2.95%+310.40%+471.34% 40.39B
+0.93%-3.15%+9.85%+102.69% 39.69B
+0.06%-1.43%+10.47%+43.27% 30.59B
-2.95%-14.09%+37.94%+1.30% 26.8B
+0.17%-6.57%-13.27%-8.23% 22.36B
Average +0.95%-5.14%+61.09%+117.44% 38.6B
Weighted average by Cap. +0.95%-5.27%+57.77%+105.85%

Financials

2026 *2027 *
Net sales 28.58B 888M 798M 745M 675M 1.27B 84.49B 1.28B 8.94B 3.49B 43.85B 3.33B 3.26B 141B 41.51B 1.29B 1.16B 1.08B 980M 1.84B 123B 1.85B 12.98B 5.07B 63.68B 4.84B 4.74B 205B
Net income 10.93B 339M 305M 285M 258M 485M 32.3B 488M 3.42B 1.33B 16.76B 1.27B 1.25B 53.91B 18.25B 567M 510M 476M 431M 809M 53.94B 814M 5.71B 2.23B 28B 2.13B 2.08B 90.04B
Net Debt -26.15B -812M -730M -681M -618M -1.16B -77.28B -1.17B -8.18B -3.19B -40.11B -3.05B -2.98B -129B -34.24B -1.06B -956M -892M -809M -1.52B -101B -1.53B -10.71B -4.18B -52.53B -3.99B -3.91B -169B
Projected Income Statement - Annual - PharmaEssentia Corporation
Logo PharmaEssentia Corporation
PHARMAESSENTIA CORPORATION is a Taiwan-based company primarily engaged in the research and development, clinical trials, manufacturing, sale, and marketing of innovative biotechnology drugs. It also oversees registration and marketing authorization applications based on product development progress. The Company focuses on hematology and oncology, utilizing the PEGylation technology platform for drug candidate design and development. The Company’s proprietary product, Ropeg, is used to treat polycythemia vera (PV), primarily sold in the United States.
Employees
131
Date Price Change Volume
14/10/26 NT$1,190.00 +2.15% 1,096,532
13/10/26 NT$1,165.00 -1.69% 1,125,456
12/10/26 NT$1,185.00 -0.84% 1,009,123
08/10/26 NT$1,195.00 -0.83% 1,844,670
07/10/26 NT$1,205.00 +2.55% 1,490,041
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - PharmaEssentia Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
1,190.00TWD
Average target price
1,482.61TWD
Spread / Average Target
+24.59%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - PharmaEssentia Corporation
  1. Stock Market
  2. Stocks
  3. 6446 Stock